Literature DB >> 34238838

Correlation of Vital Signs and Depth of Sedation by Modified Observer's Assessment of Alertness and Sedation (MOAA/S) Scale in Bronchoscopy.

Nicholas J Pastis1, Nathan T Hill1, Lonny B Yarmus2, Frank Schippers3, Mihaly Imre4, Wolfgang Sohngen5, Ostroff Randall6, Sean P Callahan7, Gerard A Silvestri1.   

Abstract

BACKGROUND: With complex, lengthy bronchoscopies, there is a need for safe, effective sedation. Most bronchoscopists strive for moderate sedation, though often difficult without compromising vital signs. The Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale is a validated 6-point scale assessing responsiveness of patients coinciding with the American Society of Anesthesiologists (ASA) continuum of sedation. It is commonly used in studying bronchoscopic sedation, but depth of sedation by MOAA/S and correlation with vital signs and adverse events has not been determined.
METHODS: This study was a post hoc analysis of a prospective, double-blind, randomized trial evaluating the safety and efficacy of remimazolam. MOAA/S and corresponding vital signs were used to assess the effect of the level of sedation on vital signs and adverse events.
RESULTS: A total of 23,341 MOAA/S scores from 431 patients were recorded. Older and higher ASA class patients spent more time in deeper sedation (MOAA/S 0 to 1) (6% vs. 2%, P=0.01). Oxygen saturation was equal in deep sedation (MOAA/S 0 to 1) (97±3%) compared with moderate sedation (96±3%) (P=0.11). Mean systolic and diastolic blood pressures were significantly lower when comparing MOAA/S 0 to 1 to MOAA/S 5 (systolic blood pressure: 126±19 vs. 147±24 mm Hg, P<0.01; diastolic blood pressure: 68±14 vs. 84±15 mm Hg, P<0.01). There was a nonsignificant trend towards lower heart rate at deep versus moderate sedation (84±15 vs. 94±18 beats/min, P=0.07). Respiratory rate was also comparable with moderate and deep sedation (17±5 vs. 18±6 beats/min, P=0.94).
CONCLUSION: There was no clinically meaningful correlation between vital signs and depth of sedation assessed by MOAA/S. Older and higher ASA class patients spend more time in deeper sedation. However, when in deep sedation, there was no difference in vital signs other than a slightly increased incidence of clinically insignificant hypotension.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34238838     DOI: 10.1097/LBR.0000000000000784

Source DB:  PubMed          Journal:  J Bronchology Interv Pulmonol        ISSN: 1948-8270


  4 in total

1.  The Efficacy and Safety of Remimazolam Tosilate Versus Dexmedetomidine in Outpatients Undergoing Flexible Bronchoscopy: A Prospective, Randomized, Blind, Non-Inferiority Trial.

Authors:  Xingfang Chen; Deqian Xin; Guangjun Xu; Jing Zhao; Qing Lv
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

2.  Moderate sedation with single-dose remimazolam tosilate in elderly male patients undergoing transurethral resection of the prostate with spinal anesthesia: a prospective, single-arm, single-centre clinical trial.

Authors:  Tang-Yuan-Meng Zhao; Hu Sun; Di Chen; Zhi-Xin Xu; Song Lyu; Tao Wang; Li-Li Liu
Journal:  BMC Anesthesiol       Date:  2022-08-04       Impact factor: 2.376

3.  Intranasal sufentanil combined with intranasal dexmedetomidine: A promising method for non-anesthesiologist sedation during endoscopic ultrasonography.

Authors:  Yong Wang; Zhi-Jun Ge; Chao Han
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

4.  ED50 and ED95 of Propofol Combined with Different Doses of Intravenous Lidocaine for First-Trimester Uterine Aspiration: A Prospective Dose-Finding Study Using Up-and-Down Sequential Allocation Method.

Authors:  Jingwen Zhang; Linglingli Kong; Juan Ni
Journal:  Drug Des Devel Ther       Date:  2022-09-28       Impact factor: 4.319

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.